HOPE

Hub @UniofOxford for Psychedelic Ethics (HOPE). News & info on ethics, law & social policy of psychedelics. Led by @briandavidearp @ExistWell via @OxNeuroEthics

[Katherine Cheung @Katherine_Chg]

See Daniel Villiger's response here!

https://t.co/bsMepF9rGU

[Katherine Cheung @Katherine_Chg]

Looking forward, systematic collection of adverse event and outcome data will be essential!

[Katherine Cheung @Katherine_Chg]

The first full year of data collected under SB 303 from Oregon's psilocybin services was recently published.

With @CaleighPropes & @ExistWell, we examine this data to give a preliminary picture as to how safety and access are being balanced in Oregon’s psilocybin services.

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

JHU PhD student Katherine Cheung and PhD Candidate Caleigh Propes, with CPCR Associate Professor Dr. David Yaden, evaluated comparison sets on the price of Oregon’s psilocybin services. As the first state in the U.S. to legalize psilocybin access and a key reference point on how other states might design psychedelic policy, this exploration helps ground discussion on Oregon’s prices in more careful analysis for future debates.

https://t.co/H4y826EzPO

[David B. Yaden @ExistWell]

Atlantic article discussing current & novel psychedelics, emphasizing parameters like expectancies, context, compound, dose, and beyond.

There is SO MUCH scientific work to do in this area to improve on preliminary work & explore altering variables that have not yet been tested!

[Brian D. Earp, Ph.D. @briandavidearp]

Analyzing the concept of independence in psychedelic research https://t.co/MXV8fknX4v

[Psychedelic Alpha @Psyched_Alpha]

American Psychiatrists’ Psychedelics Word Associations

An informal poll conducted at a psychedelics-focused session at the American Psychiatric Association’s annual meeting last month revealed common word associations that psychiatrists in attendance have with the term “psychedelic”.

Read more on our website: https://t.co/ZUFD6sZ8dU

[Katherine Cheung @Katherine_Chg]

"From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care"

https://t.co/hl9aEnBmG9

[Brian D. Earp, Ph.D. @briandavidearp]

New 🚨 "Psychedelics Are Still Not Ethically Exceptional: Rebutting Recent Claims of Uniqueness" -- new work forthcoming in Neuroethics by myself, Katherine Cheung, and David Yaden. Part of a scholarly exchange with our friend and colleague Daniel Villiger. Apologies for the generic AI image from ChatGPT. LINK: https://t.co/ALDyAkDyCJ

[David B. Yaden @ExistWell]

I appreciate the congressman said research on psychedelics is important as we need to learn more about risks/benefits/therapeutic potential. & I don't doubt he's heard stories of great benefits.

*BUT*, we now have enough data to know "magic cure" is not at all evidence-based...

[Eddie Talks Drugs @eddietalksdrugs]

An overview of the ethical spine of our argument is now live in our @bioethics_net blog:

https://t.co/4cycje12is

[11/11]

[Eddie Talks Drugs @eddietalksdrugs]

How should we approach psychedelic therapies for teenagers?

“Very carefully, very cautiously, if at all” seems like the correct (if coarse-grained) answer.

In a new paper, we articulate one concern that we think hasn't had enough attention, and sketch a response. [1/11]

[Katherine Cheung @Katherine_Chg]

"US Institutional Review Board Perspectives Regarding Psychedelic Research"

https://t.co/aBcOeuxAwB

[josh hardman @Josh__Hardman]

"...the FDA intends to release final guidance imminently to provide recommendations to sponsors developing these products."

Final Guidance for sponsors coming soon.

[Katherine Cheung @Katherine_Chg]

In this short piece w/ @CaleighPropes & @ExistWell, we explore what implicit comparison sets people might be using when making this claim.

[Katherine Cheung @Katherine_Chg]

Oregon’s psilocybin services (~$3000 at the higher end) are often described as quite expensive. But when making this claim, we should ask: expensive compared to what?

https://t.co/oalSerULFO

[Brian D. Earp, Ph.D. @briandavidearp]

Digital bioethics: exploring an emerging field - Medicine, Health Care and Philosophy https://t.co/YLUilU2U70

[Eddie Talks Drugs @eddietalksdrugs]

This was commissioned for generalist physicians, not the psychedelic research community. That constraint was clarifying. We had to decide: if a non-specialist reads one thing on this topic, what should it contain?

https://t.co/PZONdo1c9n

[Katherine Cheung @Katherine_Chg]

Original article that Daniel commented on: https://t.co/XKwZwTmrvQ

[Katherine Cheung @Katherine_Chg]

Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution

https://t.co/N2VQY0tk91